US Map / Alabama
State AL

Clinical Trials in Alabama

Recruiting clinical trials with at least one study location in Alabama. Data updated daily from ClinicalTrials.gov.

Total Trials
193
Recruiting Now
193
← Back to US Map
Top Conditions in Alabama
Heart Failure (4)Hypertension (4)Prostate Cancer (3)Ovarian Cancer (3)Multiple Myeloma (3)Breast Cancer (3)Cardiovascular Diseases (3)Asthma (2)Cancer (2)Fallopian Tube Cancer (2)Head and Neck Squamous Cell Carcinoma (2)Major Depressive Disorder (2)
NCT07258849 Phase 1
Recruiting
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Ar...
Condition
Healthy
Enrollment
134 pts
Location
United States
Sponsor
Eli Lilly and Company
View Trial →
NCT06029660 N/A
Recruiting
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of...
Condition
Aortic Aneurysm, Abdominal
Enrollment
180 pts
Location
United States, France, Netherlands
Sponsor
Shape Memory Medical, Inc.
View Trial →
NCT06744660 N/A
Recruiting
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
Condition
COVID-19
Enrollment
1,000 pts
Location
United States
Sponsor
Aptitude Medical Systems
View Trial →
NCT01042379 Phase 2
Recruiting
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast ...
Condition
Breast Neoplasms
Enrollment
5,000 pts
Location
United States
Sponsor
QuantumLeap Healthcare Collabo
View Trial →
NCT04323046 Phase 1
Recruiting
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive...
Condition
Glioblastoma
Enrollment
20 pts
Location
United States, Australia
Sponsor
Sabine Mueller, MD, PhD
View Trial →
NCT06315309 Phase 2
Recruiting
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem...
Condition
GVHD,Acute
Enrollment
29 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT06734351 Phase 3
Recruiting
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adu...
Condition
Mid Face Volume Deficit
Enrollment
231 pts
Location
United States
Sponsor
AbbVie
View Trial →
NCT05917522 Phase 2
Recruiting
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
Condition
Kidney Transplant
Enrollment
800 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT06961565 Phase 1
Recruiting
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
Condition
NF1 Mutation
Enrollment
56 pts
Location
United States, Australia, South Korea
Sponsor
Pasithea Therapeutics Corp.
View Trial →
NCT06533098 Phase 3
Recruiting
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Ri...
Condition
Thrombocytopenia, Neonatal Alloimmune
Enrollment
50 pts
Location
United States, Austria, Germany
Sponsor
Janssen Research & Development
View Trial →
NCT06496607 Phase 2
Recruiting
A Study to Evaluate Solriktug in Adult Participants With Asthma
Condition
Asthma
Enrollment
140 pts
Location
United States
Sponsor
Uniquity One (UNI)
View Trial →
NCT06774131 Phase 3
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract...
Condition
Upper Urinary Tract Urothelial Carcinoma
Enrollment
70 pts
Location
United States, Bulgaria, Georgia
Sponsor
UroGen Pharma Ltd.
View Trial →
NCT06890598 Phase 3
Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Particip...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
700 pts
Location
United States, Australia, Austria
Sponsor
Eli Lilly and Company
View Trial →
NCT05267821 Phase 2, Phase 3
Recruiting
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Condition
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)
Enrollment
500 pts
Location
United States
Sponsor
Nationwide Children's Hospital
View Trial →
NCT06056830 Phase 3
Recruiting
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-ri...
Condition
Prostate Cancer
Enrollment
383 pts
Location
United States, Australia
Sponsor
Clarity Pharmaceuticals Ltd
View Trial →
NCT07310901 Phase 1
Recruiting
A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Effic...
Condition
Obese But Otherwise Healthy Participants
Enrollment
252 pts
Location
United States
Sponsor
Corbus Pharmaceuticals Inc.
View Trial →
NCT06906367 N/A
Recruiting
A Study of Patients With Fabry Disease (US Specific)
Condition
Fabry Disease
Enrollment
450 pts
Location
United States
Sponsor
Amicus Therapeutics
View Trial →
NCT06218199 Phase 4
Recruiting
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
Condition
Heart Failure, Congestive
Enrollment
80 pts
Location
United States
Sponsor
Heart Center Research, LLC
View Trial →
Page 8 of 8 — 193 trials total
← Prev